We've found
						20,707
						 archived clinical trials in
						Gastrointestinal
					
				We've found
						20,707
						 archived clinical trials in
						Gastrointestinal
	
	Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Advanced Malignancies and Hepatic Impairment
	
Updated: 3/11/2016
  
  
  An Open-Label, Single Arm, Phase 1 Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Advanced Malignancies and Varying Degrees of Hepatic Impairment
		Status: Enrolling	
	Updated: 3/11/2016
	
	Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Advanced Malignancies and Hepatic Impairment
	
Updated: 3/11/2016
  
  
  	  An Open-Label, Single Arm, Phase 1 Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Advanced Malignancies and Varying Degrees of Hepatic Impairment
		Status: Enrolling	
	Updated: 3/11/2016
Click here to add this to my saved trials
		    
		 
	  	
	Bilicurves: Using Information Technology to Improve the Management of Neonatal Hyperbilirubinemia
	
Updated: 3/14/2016
  
  
  Bilicurves: Using Information Technology to Integrate Clinical Practice Guidelines Into the Management of Neonatal Hyperbilirubinemia
		Status: Enrolling	
	Updated: 3/14/2016
	
	Bilicurves: Using Information Technology to Improve the Management of Neonatal Hyperbilirubinemia
	
Updated: 3/14/2016
  
  
  	  Bilicurves: Using Information Technology to Integrate Clinical Practice Guidelines Into the Management of Neonatal Hyperbilirubinemia
		Status: Enrolling	
	Updated: 3/14/2016
Click here to add this to my saved trials
		    
		 
	  	
	Pentoxifylline Treatment of Acute Pancreatitis
	
Updated: 3/14/2016
  
  
  Pentoxifylline Treatment in Acute Pancreatitis; A Double-Blind Placebo-Controlled Randomized Trial
		Status: Enrolling	
	Updated: 3/14/2016
	
	Pentoxifylline Treatment of Acute Pancreatitis
	
Updated: 3/14/2016
  
  
  	  Pentoxifylline Treatment in Acute Pancreatitis; A Double-Blind Placebo-Controlled Randomized Trial
		Status: Enrolling	
	Updated: 3/14/2016
Click here to add this to my saved trials
		    
		 
	  	
	Rebound Hernia Repair Device Mesh Trial
	
Updated: 3/14/2016
  
  
  Rebound Hernia Repair Device Trial
		Status: Enrolling	
	Updated: 3/14/2016
	
	Rebound Hernia Repair Device Mesh Trial
	
Updated: 3/14/2016
  
  
  	  Rebound Hernia Repair Device Trial
		Status: Enrolling	
	Updated: 3/14/2016
Click here to add this to my saved trials
		    
		 
	  	
	Rebound Hernia Repair Device Mesh Trial
	
Updated: 3/14/2016
  
  
  Rebound Hernia Repair Device Trial
		Status: Enrolling	
	Updated: 3/14/2016
	
	Rebound Hernia Repair Device Mesh Trial
	
Updated: 3/14/2016
  
  
  	  Rebound Hernia Repair Device Trial
		Status: Enrolling	
	Updated: 3/14/2016
Click here to add this to my saved trials
		    
		 
	  	
	Human Amniotic Membrane Grafting and Standard of Care Versus Standard of Care Alone in the Treatment of Venous Leg Ulcers
	
Updated: 3/14/2016
  
  
  A Multi-center Randomized Controlled Clinical Trial Evaluating Two Application Regimens of Human Amniotic Membrane Grafting and Standard of Care Versus Standard of Care Alone in the Treatment of Venous Leg Ulcers.
		Status: Enrolling	
	Updated: 3/14/2016
	
	Human Amniotic Membrane Grafting and Standard of Care Versus Standard of Care Alone in the Treatment of Venous Leg Ulcers
	
Updated: 3/14/2016
  
  
  	  A Multi-center Randomized Controlled Clinical Trial Evaluating Two Application Regimens of Human Amniotic Membrane Grafting and Standard of Care Versus Standard of Care Alone in the Treatment of Venous Leg Ulcers.
		Status: Enrolling	
	Updated: 3/14/2016
Click here to add this to my saved trials
		    
		 
	  	
	Human Amniotic Membrane Grafting and Standard of Care Versus Standard of Care Alone in the Treatment of Venous Leg Ulcers
	
Updated: 3/14/2016
  
  
  A Multi-center Randomized Controlled Clinical Trial Evaluating Two Application Regimens of Human Amniotic Membrane Grafting and Standard of Care Versus Standard of Care Alone in the Treatment of Venous Leg Ulcers.
		Status: Enrolling	
	Updated: 3/14/2016
	
	Human Amniotic Membrane Grafting and Standard of Care Versus Standard of Care Alone in the Treatment of Venous Leg Ulcers
	
Updated: 3/14/2016
  
  
  	  A Multi-center Randomized Controlled Clinical Trial Evaluating Two Application Regimens of Human Amniotic Membrane Grafting and Standard of Care Versus Standard of Care Alone in the Treatment of Venous Leg Ulcers.
		Status: Enrolling	
	Updated: 3/14/2016
Click here to add this to my saved trials
		    
		 
	  	
	Human Amniotic Membrane Grafting and Standard of Care Versus Standard of Care Alone in the Treatment of Venous Leg Ulcers
	
Updated: 3/14/2016
  
  
  A Multi-center Randomized Controlled Clinical Trial Evaluating Two Application Regimens of Human Amniotic Membrane Grafting and Standard of Care Versus Standard of Care Alone in the Treatment of Venous Leg Ulcers.
		Status: Enrolling	
	Updated: 3/14/2016
	
	Human Amniotic Membrane Grafting and Standard of Care Versus Standard of Care Alone in the Treatment of Venous Leg Ulcers
	
Updated: 3/14/2016
  
  
  	  A Multi-center Randomized Controlled Clinical Trial Evaluating Two Application Regimens of Human Amniotic Membrane Grafting and Standard of Care Versus Standard of Care Alone in the Treatment of Venous Leg Ulcers.
		Status: Enrolling	
	Updated: 3/14/2016
Click here to add this to my saved trials
		    
		 
	  	
	Human Amniotic Membrane Grafting and Standard of Care Versus Standard of Care Alone in the Treatment of Venous Leg Ulcers
	
Updated: 3/14/2016
  
  
  A Multi-center Randomized Controlled Clinical Trial Evaluating Two Application Regimens of Human Amniotic Membrane Grafting and Standard of Care Versus Standard of Care Alone in the Treatment of Venous Leg Ulcers.
		Status: Enrolling	
	Updated: 3/14/2016
	
	Human Amniotic Membrane Grafting and Standard of Care Versus Standard of Care Alone in the Treatment of Venous Leg Ulcers
	
Updated: 3/14/2016
  
  
  	  A Multi-center Randomized Controlled Clinical Trial Evaluating Two Application Regimens of Human Amniotic Membrane Grafting and Standard of Care Versus Standard of Care Alone in the Treatment of Venous Leg Ulcers.
		Status: Enrolling	
	Updated: 3/14/2016
Click here to add this to my saved trials
		    
		 
	  	
	Human Amniotic Membrane Grafting and Standard of Care Versus Standard of Care Alone in the Treatment of Venous Leg Ulcers
	
Updated: 3/14/2016
  
  
  A Multi-center Randomized Controlled Clinical Trial Evaluating Two Application Regimens of Human Amniotic Membrane Grafting and Standard of Care Versus Standard of Care Alone in the Treatment of Venous Leg Ulcers.
		Status: Enrolling	
	Updated: 3/14/2016
	
	Human Amniotic Membrane Grafting and Standard of Care Versus Standard of Care Alone in the Treatment of Venous Leg Ulcers
	
Updated: 3/14/2016
  
  
  	  A Multi-center Randomized Controlled Clinical Trial Evaluating Two Application Regimens of Human Amniotic Membrane Grafting and Standard of Care Versus Standard of Care Alone in the Treatment of Venous Leg Ulcers.
		Status: Enrolling	
	Updated: 3/14/2016
Click here to add this to my saved trials
		    
		 
	  	
	A Study to Investigate How the Study Drug SHP626 is Eliminated From the Body After One Dose
	
Updated: 3/14/2016
  
  
  A Phase 1, Open-label Study to Investigate the Absorption, Distribution, Metabolism, and Excretion of [14C]-SHP626 Following a Single Oral Dose in Healthy Male Subjects
		Status: Enrolling	
	Updated: 3/14/2016
	
	A Study to Investigate How the Study Drug SHP626 is Eliminated From the Body After One Dose
	
Updated: 3/14/2016
  
  
  	  A Phase 1, Open-label Study to Investigate the Absorption, Distribution, Metabolism, and Excretion of [14C]-SHP626 Following a Single Oral Dose in Healthy Male Subjects
		Status: Enrolling	
	Updated: 3/14/2016
Click here to add this to my saved trials
		    
		 
	  	
	A Trial of Esophageal and Gastric Stenting for Leak or Perforation
	
Updated: 3/15/2016
  
  
  A Phase II Trial of Esophageal and Gastric Stenting for Leak or Perforation
		Status: Enrolling	
	Updated: 3/15/2016
	
	A Trial of Esophageal and Gastric Stenting for Leak or Perforation
	
Updated: 3/15/2016
  
  
  	  A Phase II Trial of Esophageal and Gastric Stenting for Leak or Perforation
		Status: Enrolling	
	Updated: 3/15/2016
Click here to add this to my saved trials
		    
		 
	  	
	APT001 Plasma/NO Generator to Treat Diabetic Foot Ulcer in Adults
	
Updated: 3/15/2016
  
  
  A Pivotal Study of the Use of Nitric Oxide / Plasma Therapy as Produced by the APT001 Plasma / Nitric Oxide Generator in Adult Subjects With a Diabetic Foot Ulcer
		Status: Enrolling	
	Updated: 3/15/2016
	
	APT001 Plasma/NO Generator to Treat Diabetic Foot Ulcer in Adults
	
Updated: 3/15/2016
  
  
  	  A Pivotal Study of the Use of Nitric Oxide / Plasma Therapy as Produced by the APT001 Plasma / Nitric Oxide Generator in Adult Subjects With a Diabetic Foot Ulcer
		Status: Enrolling	
	Updated: 3/15/2016
Click here to add this to my saved trials
		    
		 
	  	
	APT001 Plasma/NO Generator to Treat Diabetic Foot Ulcer in Adults
	
Updated: 3/15/2016
  
  
  A Pivotal Study of the Use of Nitric Oxide / Plasma Therapy as Produced by the APT001 Plasma / Nitric Oxide Generator in Adult Subjects With a Diabetic Foot Ulcer
		Status: Enrolling	
	Updated: 3/15/2016
	
	APT001 Plasma/NO Generator to Treat Diabetic Foot Ulcer in Adults
	
Updated: 3/15/2016
  
  
  	  A Pivotal Study of the Use of Nitric Oxide / Plasma Therapy as Produced by the APT001 Plasma / Nitric Oxide Generator in Adult Subjects With a Diabetic Foot Ulcer
		Status: Enrolling	
	Updated: 3/15/2016
Click here to add this to my saved trials
		    
		 
	  	
	APT001 Plasma/NO Generator to Treat Diabetic Foot Ulcer in Adults
	
Updated: 3/15/2016
  
  
  A Pivotal Study of the Use of Nitric Oxide / Plasma Therapy as Produced by the APT001 Plasma / Nitric Oxide Generator in Adult Subjects With a Diabetic Foot Ulcer
		Status: Enrolling	
	Updated: 3/15/2016
	
	APT001 Plasma/NO Generator to Treat Diabetic Foot Ulcer in Adults
	
Updated: 3/15/2016
  
  
  	  A Pivotal Study of the Use of Nitric Oxide / Plasma Therapy as Produced by the APT001 Plasma / Nitric Oxide Generator in Adult Subjects With a Diabetic Foot Ulcer
		Status: Enrolling	
	Updated: 3/15/2016
Click here to add this to my saved trials
		    
		 
	  	
	APT001 Plasma/NO Generator to Treat Diabetic Foot Ulcer in Adults
	
Updated: 3/15/2016
  
  
  A Pivotal Study of the Use of Nitric Oxide / Plasma Therapy as Produced by the APT001 Plasma / Nitric Oxide Generator in Adult Subjects With a Diabetic Foot Ulcer
		Status: Enrolling	
	Updated: 3/15/2016
	
	APT001 Plasma/NO Generator to Treat Diabetic Foot Ulcer in Adults
	
Updated: 3/15/2016
  
  
  	  A Pivotal Study of the Use of Nitric Oxide / Plasma Therapy as Produced by the APT001 Plasma / Nitric Oxide Generator in Adult Subjects With a Diabetic Foot Ulcer
		Status: Enrolling	
	Updated: 3/15/2016
Click here to add this to my saved trials
		    
		 
	  	
	hCAP18 Levels and Vitamin D Deficiency in Healthy Subjects
	
Updated: 3/15/2016
  
  
  hCAP18 Levels and Vitamin D Deficiency in Healthy Subjects
		Status: Enrolling	
	Updated: 3/15/2016
	
	hCAP18 Levels and Vitamin D Deficiency in Healthy Subjects
	
Updated: 3/15/2016
  
  
  	  hCAP18 Levels and Vitamin D Deficiency in Healthy Subjects
		Status: Enrolling	
	Updated: 3/15/2016
Click here to add this to my saved trials
		    
		 
	  	
	A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of ASP2215
	
Updated: 3/17/2016
  
  
  A Phase 1 Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of ASP2215
		Status: Enrolling	
	Updated: 3/17/2016
	
	A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of ASP2215
	
Updated: 3/17/2016
  
  
  	  A Phase 1 Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of ASP2215
		Status: Enrolling	
	Updated: 3/17/2016
Click here to add this to my saved trials
		    
		 
	  	
	Phase II Study of Irinotecan and Panitumumab
	
Updated: 3/18/2016
  
  
  Phase II Study of Irinotecan and Panitumumab as Second-Line Therapy for Patients With Advanced Esophageal Adenocarcinoma
		Status: Enrolling	
	Updated: 3/18/2016
	
	Phase II Study of Irinotecan and Panitumumab
	
Updated: 3/18/2016
  
  
  	  Phase II Study of Irinotecan and Panitumumab as Second-Line Therapy for Patients With Advanced Esophageal Adenocarcinoma
		Status: Enrolling	
	Updated: 3/18/2016
Click here to add this to my saved trials
		    
		 
	  	
	Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial
	
Updated: 3/18/2016
  
  
  Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin: A Multicenter, Randomized, Double-Masked, Placebo-Controlled Trial
		Status: Enrolling	
	Updated: 3/18/2016
	
	Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial
	
Updated: 3/18/2016
  
  
  	  Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin: A Multicenter, Randomized, Double-Masked, Placebo-Controlled Trial
		Status: Enrolling	
	Updated: 3/18/2016
Click here to add this to my saved trials
		    
		 
	  	
	Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial
	
Updated: 3/18/2016
  
  
  Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin: A Multicenter, Randomized, Double-Masked, Placebo-Controlled Trial
		Status: Enrolling	
	Updated: 3/18/2016
	
	Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial
	
Updated: 3/18/2016
  
  
  	  Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin: A Multicenter, Randomized, Double-Masked, Placebo-Controlled Trial
		Status: Enrolling	
	Updated: 3/18/2016
Click here to add this to my saved trials
		    
		 
	  	
	Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial
	
Updated: 3/18/2016
  
  
  Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin: A Multicenter, Randomized, Double-Masked, Placebo-Controlled Trial
		Status: Enrolling	
	Updated: 3/18/2016
	
	Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial
	
Updated: 3/18/2016
  
  
  	  Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin: A Multicenter, Randomized, Double-Masked, Placebo-Controlled Trial
		Status: Enrolling	
	Updated: 3/18/2016
Click here to add this to my saved trials
		    
		 
	  	
	Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial
	
Updated: 3/18/2016
  
  
  Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin: A Multicenter, Randomized, Double-Masked, Placebo-Controlled Trial
		Status: Enrolling	
	Updated: 3/18/2016
	
	Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial
	
Updated: 3/18/2016
  
  
  	  Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin: A Multicenter, Randomized, Double-Masked, Placebo-Controlled Trial
		Status: Enrolling	
	Updated: 3/18/2016
Click here to add this to my saved trials
		    
		 
	  	
	Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial
	
Updated: 3/18/2016
  
  
  Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin: A Multicenter, Randomized, Double-Masked, Placebo-Controlled Trial
		Status: Enrolling	
	Updated: 3/18/2016
	
	Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial
	
Updated: 3/18/2016
  
  
  	  Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin: A Multicenter, Randomized, Double-Masked, Placebo-Controlled Trial
		Status: Enrolling	
	Updated: 3/18/2016
Click here to add this to my saved trials
		    
		 
	  	
	Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial
	
Updated: 3/18/2016
  
  
  Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin: A Multicenter, Randomized, Double-Masked, Placebo-Controlled Trial
		Status: Enrolling	
	Updated: 3/18/2016
	
	Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial
	
Updated: 3/18/2016
  
  
  	  Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin: A Multicenter, Randomized, Double-Masked, Placebo-Controlled Trial
		Status: Enrolling	
	Updated: 3/18/2016
Click here to add this to my saved trials
		    
		 
	  	
	Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial
	
Updated: 3/18/2016
  
  
  Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin: A Multicenter, Randomized, Double-Masked, Placebo-Controlled Trial
		Status: Enrolling	
	Updated: 3/18/2016
	
	Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial
	
Updated: 3/18/2016
  
  
  	  Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin: A Multicenter, Randomized, Double-Masked, Placebo-Controlled Trial
		Status: Enrolling	
	Updated: 3/18/2016
Click here to add this to my saved trials
		    
		 
	  	
	Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial
	
Updated: 3/18/2016
  
  
  Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin: A Multicenter, Randomized, Double-Masked, Placebo-Controlled Trial
		Status: Enrolling	
	Updated: 3/18/2016
	
	Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial
	
Updated: 3/18/2016
  
  
  	  Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin: A Multicenter, Randomized, Double-Masked, Placebo-Controlled Trial
		Status: Enrolling	
	Updated: 3/18/2016
Click here to add this to my saved trials
		    
		 
	  	
	Efficacy and Safety of Zoledronic Acid in Acute Spinal Cord Injury: Prevention of Bone Loss
	
Updated: 3/21/2016
  
  
  Efficacy and Safety of Zoledronic Acid in Acute Spinal Cord Injury: Prevention of Bone Loss
		Status: Enrolling	
	Updated: 3/21/2016
	
	Efficacy and Safety of Zoledronic Acid in Acute Spinal Cord Injury: Prevention of Bone Loss
	
Updated: 3/21/2016
  
  
  	  Efficacy and Safety of Zoledronic Acid in Acute Spinal Cord Injury: Prevention of Bone Loss
		Status: Enrolling	
	Updated: 3/21/2016
Click here to add this to my saved trials
		    
		 
	  	
	A Pilot Study of the Treatment of Eosinophilic Esophagitis With Omalizumab
	
Updated: 3/21/2016
  
  
  A Pilot Study of the Treatment of Eosinophilic Esophagitis With Omalizumab
		Status: Enrolling	
	Updated: 3/21/2016
	
	A Pilot Study of the Treatment of Eosinophilic Esophagitis With Omalizumab
	
Updated: 3/21/2016
  
  
  	  A Pilot Study of the Treatment of Eosinophilic Esophagitis With Omalizumab
		Status: Enrolling	
	Updated: 3/21/2016
Click here to add this to my saved trials
		    
		 
	  	
	Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
	
Updated: 3/23/2016
  
  
  A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
		Status: Enrolling	
	Updated: 3/23/2016
	
	Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
	
Updated: 3/23/2016
  
  
  	  A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
		Status: Enrolling	
	Updated: 3/23/2016
Click here to add this to my saved trials
		    
		 
	  	
	Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
	
Updated: 3/23/2016
  
  
  A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
		Status: Enrolling	
	Updated: 3/23/2016
	
	Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
	
Updated: 3/23/2016
  
  
  	  A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
		Status: Enrolling	
	Updated: 3/23/2016
Click here to add this to my saved trials
		    
		 
	  	
	Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
	
Updated: 3/23/2016
  
  
  A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
		Status: Enrolling	
	Updated: 3/23/2016
	
	Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
	
Updated: 3/23/2016
  
  
  	  A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
		Status: Enrolling	
	Updated: 3/23/2016
Click here to add this to my saved trials
		    
		 
	  	
	Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
	
Updated: 3/23/2016
  
  
  A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
		Status: Enrolling	
	Updated: 3/23/2016
	
	Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
	
Updated: 3/23/2016
  
  
  	  A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
		Status: Enrolling	
	Updated: 3/23/2016
Click here to add this to my saved trials
		    
		 
	  	
	Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
	
Updated: 3/23/2016
  
  
  A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
		Status: Enrolling	
	Updated: 3/23/2016
	
	Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
	
Updated: 3/23/2016
  
  
  	  A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
		Status: Enrolling	
	Updated: 3/23/2016
Click here to add this to my saved trials
		    
		 
	  	
	Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
	
Updated: 3/23/2016
  
  
  A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
		Status: Enrolling	
	Updated: 3/23/2016
	
	Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
	
Updated: 3/23/2016
  
  
  	  A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
		Status: Enrolling	
	Updated: 3/23/2016
Click here to add this to my saved trials
		    
		 
	  	
	Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
	
Updated: 3/23/2016
  
  
  A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
		Status: Enrolling	
	Updated: 3/23/2016
	
	Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
	
Updated: 3/23/2016
  
  
  	  A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
		Status: Enrolling	
	Updated: 3/23/2016
Click here to add this to my saved trials
		    
		 
	  	
	Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
	
Updated: 3/23/2016
  
  
  A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
		Status: Enrolling	
	Updated: 3/23/2016
	
	Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
	
Updated: 3/23/2016
  
  
  	  A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
		Status: Enrolling	
	Updated: 3/23/2016
Click here to add this to my saved trials
		    
		 
	  	
	Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
	
Updated: 3/23/2016
  
  
  A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
		Status: Enrolling	
	Updated: 3/23/2016
	
	Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
	
Updated: 3/23/2016
  
  
  	  A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
		Status: Enrolling	
	Updated: 3/23/2016
Click here to add this to my saved trials
		    
		 
	  	
	Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
	
Updated: 3/23/2016
  
  
  A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
		Status: Enrolling	
	Updated: 3/23/2016
	
	Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
	
Updated: 3/23/2016
  
  
  	  A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
		Status: Enrolling	
	Updated: 3/23/2016
Click here to add this to my saved trials
		    
		 
	  	
	Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
	
Updated: 3/23/2016
  
  
  A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
		Status: Enrolling	
	Updated: 3/23/2016
	
	Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
	
Updated: 3/23/2016
  
  
  	  A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
		Status: Enrolling	
	Updated: 3/23/2016
Click here to add this to my saved trials
		    
		 
	  	
	Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
	
Updated: 3/23/2016
  
  
  A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
		Status: Enrolling	
	Updated: 3/23/2016
	
	Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
	
Updated: 3/23/2016
  
  
  	  A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
		Status: Enrolling	
	Updated: 3/23/2016
Click here to add this to my saved trials
		    
		 
	  	
	Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
	
Updated: 3/23/2016
  
  
  A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
		Status: Enrolling	
	Updated: 3/23/2016
	
	Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
	
Updated: 3/23/2016
  
  
  	  A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
		Status: Enrolling	
	Updated: 3/23/2016
Click here to add this to my saved trials
		    
		 
	  	
	Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
	
Updated: 3/23/2016
  
  
  A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
		Status: Enrolling	
	Updated: 3/23/2016
	
	Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
	
Updated: 3/23/2016
  
  
  	  A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
		Status: Enrolling	
	Updated: 3/23/2016
Click here to add this to my saved trials
		    
		 
	  	
	Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
	
Updated: 3/23/2016
  
  
  A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
		Status: Enrolling	
	Updated: 3/23/2016
	
	Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
	
Updated: 3/23/2016
  
  
  	  A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
		Status: Enrolling	
	Updated: 3/23/2016
Click here to add this to my saved trials
		    
		 
	  	
	Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
	
Updated: 3/23/2016
  
  
  A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
		Status: Enrolling	
	Updated: 3/23/2016
	
	Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
	
Updated: 3/23/2016
  
  
  	  A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
		Status: Enrolling	
	Updated: 3/23/2016
Click here to add this to my saved trials
		    
		 
	  	
	Vitamin D and Carboxy PTH Fragments in Coronary Calcification
	
Updated: 3/25/2016
  
  
  A Prospective, Randomized, Open-Label Trial Investigating the Effect of 1 Alpha Hydroxy Vitamin D2 on the Development of Coronary Calcification in New ESRD Patients Using the 1-84/7-84 PTH Ratio to Determine Dosing
		Status: Enrolling	
	Updated: 3/25/2016
	
	Vitamin D and Carboxy PTH Fragments in Coronary Calcification
	
Updated: 3/25/2016
  
  
  	  A Prospective, Randomized, Open-Label Trial Investigating the Effect of 1 Alpha Hydroxy Vitamin D2 on the Development of Coronary Calcification in New ESRD Patients Using the 1-84/7-84 PTH Ratio to Determine Dosing
		Status: Enrolling	
	Updated: 3/25/2016
Click here to add this to my saved trials
		    
		 
	  	
	An Efficacy Study in Gastric and Gastroesophageal Junction Cancer Comparing Ipilimumab Versus Standard of Care Immediately Following First Line Chemotherapy
	
Updated: 3/25/2016
  
  
  A Randomized, Open-label, Two-arm Phase II Trial Comparing the Efficacy of Sequential Ipilimumab Versus Best Supportive Care Following First-line Chemotherapy in Subjects With Unresectable Locally Advanced/Metastatic Gastric or Gastro-esophageal Junction Cancer
		Status: Enrolling	
	Updated: 3/25/2016
	
	An Efficacy Study in Gastric and Gastroesophageal Junction Cancer Comparing Ipilimumab Versus Standard of Care Immediately Following First Line Chemotherapy
	
Updated: 3/25/2016
  
  
  	  A Randomized, Open-label, Two-arm Phase II Trial Comparing the Efficacy of Sequential Ipilimumab Versus Best Supportive Care Following First-line Chemotherapy in Subjects With Unresectable Locally Advanced/Metastatic Gastric or Gastro-esophageal Junction Cancer
		Status: Enrolling	
	Updated: 3/25/2016
Click here to add this to my saved trials
		    
		 
	  	
	An Efficacy Study in Gastric and Gastroesophageal Junction Cancer Comparing Ipilimumab Versus Standard of Care Immediately Following First Line Chemotherapy
	
Updated: 3/25/2016
  
  
  A Randomized, Open-label, Two-arm Phase II Trial Comparing the Efficacy of Sequential Ipilimumab Versus Best Supportive Care Following First-line Chemotherapy in Subjects With Unresectable Locally Advanced/Metastatic Gastric or Gastro-esophageal Junction Cancer
		Status: Enrolling	
	Updated: 3/25/2016
	
	An Efficacy Study in Gastric and Gastroesophageal Junction Cancer Comparing Ipilimumab Versus Standard of Care Immediately Following First Line Chemotherapy
	
Updated: 3/25/2016
  
  
  	  A Randomized, Open-label, Two-arm Phase II Trial Comparing the Efficacy of Sequential Ipilimumab Versus Best Supportive Care Following First-line Chemotherapy in Subjects With Unresectable Locally Advanced/Metastatic Gastric or Gastro-esophageal Junction Cancer
		Status: Enrolling	
	Updated: 3/25/2016
Click here to add this to my saved trials
		    
		 
	  	
	An Efficacy Study in Gastric and Gastroesophageal Junction Cancer Comparing Ipilimumab Versus Standard of Care Immediately Following First Line Chemotherapy
	
Updated: 3/25/2016
  
  
  A Randomized, Open-label, Two-arm Phase II Trial Comparing the Efficacy of Sequential Ipilimumab Versus Best Supportive Care Following First-line Chemotherapy in Subjects With Unresectable Locally Advanced/Metastatic Gastric or Gastro-esophageal Junction Cancer
		Status: Enrolling	
	Updated: 3/25/2016
	
	An Efficacy Study in Gastric and Gastroesophageal Junction Cancer Comparing Ipilimumab Versus Standard of Care Immediately Following First Line Chemotherapy
	
Updated: 3/25/2016
  
  
  	  A Randomized, Open-label, Two-arm Phase II Trial Comparing the Efficacy of Sequential Ipilimumab Versus Best Supportive Care Following First-line Chemotherapy in Subjects With Unresectable Locally Advanced/Metastatic Gastric or Gastro-esophageal Junction Cancer
		Status: Enrolling	
	Updated: 3/25/2016
Click here to add this to my saved trials
		    
		 
	  	
	An Efficacy Study in Gastric and Gastroesophageal Junction Cancer Comparing Ipilimumab Versus Standard of Care Immediately Following First Line Chemotherapy
	
Updated: 3/25/2016
  
  
  A Randomized, Open-label, Two-arm Phase II Trial Comparing the Efficacy of Sequential Ipilimumab Versus Best Supportive Care Following First-line Chemotherapy in Subjects With Unresectable Locally Advanced/Metastatic Gastric or Gastro-esophageal Junction Cancer
		Status: Enrolling	
	Updated: 3/25/2016
	
	An Efficacy Study in Gastric and Gastroesophageal Junction Cancer Comparing Ipilimumab Versus Standard of Care Immediately Following First Line Chemotherapy
	
Updated: 3/25/2016
  
  
  	  A Randomized, Open-label, Two-arm Phase II Trial Comparing the Efficacy of Sequential Ipilimumab Versus Best Supportive Care Following First-line Chemotherapy in Subjects With Unresectable Locally Advanced/Metastatic Gastric or Gastro-esophageal Junction Cancer
		Status: Enrolling	
	Updated: 3/25/2016
Click here to add this to my saved trials
		    
		 
	  